Evidence map›Paper›PMID 41649227›Full record

ArticleInvestigative ophthalmology & visual science2026

Crosstalk Between R-Loops, RNA/DNA Modifications, and Cell Death Dynamics in Canine Models of Retinitis Pigmentosa.

Tatyana Appelbaum, David A Smith, Kei Takahashi, Raghavi Sudharsan, William A Beltran

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatyana AppelbaumDivision of Experimental Retinal Therapies, Department of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
David A SmithDivision of Experimental Retinal Therapies, Department of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Kei TakahashiDivision of Experimental Retinal Therapies, Department of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Raghavi SudharsanDivision of Experimental Retinal Therapies, Department of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
William A BeltranDivision of Experimental Retinal Therapies, Department of Clinical Sciences & Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.

Funding

MODELS OF HEREDITY RETINAL DEGENERATIONR01EY006855 · NEI · UNIVERSITY OF PENNSYLVANIA · PI GUSTAVO David AGUIRRE, William A. Beltran · 1992 to 2026
$20.7M
Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5M
Translational Research for Retinal Degeneration TherapiesR01EY017549 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BELTRAN, WILLIAM A. · 2007 to 2024
$14.1M
Leica Stellaris 8 Falcon/FLIM for the PennVet Imaging CoreS10OD032305 · OD · UNIVERSITY OF PENNSYLVANIA · PI FREEDMAN, BRUCE D · 2023 to 2023
$842k
NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY006855NEI NIH HHS R01 EY017549NIH HHS S10 OD032305
6 · The paper itself

Abstract

Purpose: Mutations in RPGRorf15 and PDE6B cause early-onset retinitis pigmentosa, yet the molecular factors driving photoreceptor degeneration remain poorly understood. Here, we characterize the pathological accumulation of RNA:DNA hybrids (R-loops) in two canine disease models-xlpra2/RPGRorf15 and rcd1/PDE6B-to provide new insights into disease pathogenesis. Methods: Archival canine retinal tissues were used for immunohistochemistry, TUNEL, Western blotting, and PCR. Outer nuclear layer regions were isolated via laser-capture microdissection to assess gene expression changes. Results: R-loop dynamics paralleled progression of apoptosis in both models. Most TUNEL-positive photoreceptor nuclei were also positive for R-loops and m⁶A RNA modification, suggesting potential crosstalk. Near peak apoptosis, colabeled nuclei accounted for ∼68% to 79% in xlpra2 (7-8 weeks old) and 59% to 78% in rcd1 (3-6 weeks old), although TUNEL-only nuclei were also present. At later stages (16 weeks), colabeling ranged from 76% to 100% in xlpra2 and 52% to 53% in rcd1. By 16 weeks, R-loop accumulation declined in both models, whereas γH2AX, a marker of early DNA double-strand breaks, increased. Downregulation of genes controlling R-loop metabolism was evident at 6 to 7 weeks, including CPSF6 and XRN2 (both models), as well as BRD4 and SF3B1 in xlpra2 and DHX9 in rcd1. These alterations may partly underlie the disease-associated splicing defects observed in RPGRorf15 pre-mRNA, encoded by the R-loop-prone ORF15 locus. Conclusions: Photoreceptor degeneration in xlpra2 and rcd1 is accompanied by overlapping molecular features, including early R-loop- and m⁶A-associated apoptosis with concurrent transcriptional alterations in R-loop-regulatory genes, followed by a progressively R-loop-independent DNA damage response.

Indexed as

ApoptosisDNARetinitis PigmentosaR-Loop StructuresRNAAnimalsBlotting, WesternDisease Models, AnimalDogsEye ProteinsGene Expression RegulationImmunohistochemistryIn Situ Nick-End LabelingPhotoreceptor Cells, VertebrateDNAEye ProteinsRNA

Identifiers

PMID41649227
PMCPMC12889176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.